CompletedN/AOther

Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry

Sponsored by Novartis

NCT ID
NCT06662812
Target Enrollment
1,665 participants
Start Date
2021-10-06
Est. Completion
2023-12-01

About This Study

This was a retrospective observational cohort study. This study was a secondary analysis of individuals with sickle cell disease (SCD) enrolled in the GRNDaD registry.

Conditions Studied

Sickle Cell Disease

Eligibility

Healthy Volunteers:No
View full eligibility criteria
Inclusion criteria:

* Diagnosis of SCD.
* Signed consent to participate in GRNDaD registry.

Exclusion criteria:

• None identified at this time.

Study Locations (1)

Novartis Pharmaceuticals
East Hanover, New Jersey, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry | Huxley